The head shot is the latest in a long line of cures that have been tested on humans.
We spoke with Dr. Leah Gynecologist about the latest, the first to be confirmed, and whether she thinks there’s hope for treating the epidemic.
Are there new drugs to treat the epidemic?
Dr. Leah, let’s start by saying that there’s been a lot of excitement about these new drugs, so I can understand why people are excited.
I’m actually not a drug researcher, and I can’t tell you how many drugs are being developed at this time, and the ones that are getting the most attention are probably the ones I think of as “natural.”
So, we’re talking about vaccines, which are really novel because they’re not based on any existing biological material.
So, you have to take into account that in order to do it, you need to get rid of that material in a way that is nontoxic.
So the best way to do that is to get some of the virus into your body, but it’s still going to get to your brain.
Then there are a number of other drugs, and there’s a bunch of different types of antibodies that are used to fight infections, and they are going to do different things depending on the virus.
But in general, we don’t really know what they are.
We don’t know whether they are good against the HIV-1 strain that we’re dealing with, or whether they can help against the other strains that are out there.
So it’s kind of like trying to put a hat on a hat.
We have no idea how they’re going to work in people, but they can be very effective, especially in people who have been treated for a long time, or who have had some other type of infection.
There are also some studies that have suggested that if you can get the antibodies to work against these other strains, they can also help people who are chronically infected, as well.
We’ve been working on vaccines for about a decade now.
It’s been an incredible journey.
But it’s also been really challenging, because there’s so much that we don and don’t understand about how these different strains work, and how they can interact.
And it’s just a huge challenge for the pharmaceutical industry to figure out how to make it safe and effective.
I think we’ve learned a lot about how to do this.
We also have some things that are still very basic, which is to treat viruses like they’re viruses, not as an immune system that is able to fight them.
So you need a virus, and you need the virus to get into your cell.
And the first thing that’s really important is to make sure that it doesn’t get out of the cell.
So if it does get out, you can’t use the vaccine to treat it, because it would be a lot harder to get it into the cells than it is to use it to kill it.
Then you need antibodies, and antibodies are really hard to make, and so you have the problem of making antibodies that can work against the virus and not the virus itself.
So antibodies don’t work well in cells, and that’s what you have.
Then, there are also a bunch and a half other things that have to be taken into account, and then we have to figure what to do with it, and we’re still in the early stages.
So that’s one of the challenges.
I do think that it’s an incredible achievement that we’ve been able to get a vaccine out there that works in people.
But then, the other thing that we have is, if you look at the literature, there’s only a handful of studies that look at this.
So there’s nothing really that is proving that it works, and in some cases, it’s really contradictory, because in some studies, there was an increase in HIV-2 infection in people that got the shot, and other studies showed no increase in infection.
So we’re trying to figure that out, and it’s a big, huge, complex question.
So I don’t think there’s really a whole lot that we know that we can say, “OK, this is going to be safe.”
I think that we really need to look at other things, like we’ve seen with some of these antibodies that we are looking at, that have a lot more activity in the immune system than the ones we’ve gotten so far, and some of them are really powerful, like the ones against hepatitis B, and maybe some of those will work better against other strains.
So maybe there is some hope.
The other thing is that we haven’t really had any data on these drugs in humans, and this has led some people to believe that there is a real risk that we may be taking people off the vaccine prematurely, because they are so young